| Flow cytometry: basic principles and applications A Adan, G Alizada, Y Kiraz, Y Baran, A Nalbant Critical reviews in biotechnology 37 (2), 163-176, 2017 | 1254 | 2017 |
| Major apoptotic mechanisms and genes involved in apoptosis Y Kiraz, A Adan, M Kartal Yandim, Y Baran Tumor Biology 37, 8471-8486, 2016 | 587 | 2016 |
| Cell proliferation and cytotoxicity assays A Adan, Y Kiraz, Y Baran Current pharmaceutical biotechnology 17 (14), 1213-1221, 2016 | 563 | 2016 |
| Molecular mechanisms of drug resistance and its reversal in cancer M Kartal-Yandim, A Adan-Gokbulut, Y Baran Critical reviews in biotechnology 36 (4), 716-726, 2016 | 331 | 2016 |
| Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells Y Baran, A Salas, CE Senkal, U Gunduz, J Bielawski, LM Obeid, ... Journal of Biological Chemistry 282 (15), 10922-10934, 2007 | 268 | 2007 |
| Granulocytic sarcoma: a systematic review AF Yilmaz, G Saydam, F Sahin, Y Baran American journal of blood research 3 (4), 265, 2013 | 243 | 2013 |
| Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A A Salas, S Ponnusamy, CE Senkal, M Meyers-Needham, SP Selvam, ... Blood, The Journal of the American Society of Hematology 117 (22), 5941-5952, 2011 | 150 | 2011 |
| An update on molecular biology of thyroid cancers O Omur, Y Baran Critical reviews in oncology/hematology 90 (3), 233-252, 2014 | 142 | 2014 |
| Cytotoxic effects of four different endodontic materials in human periodontal ligament fibroblasts M Gorduysus, N Avcu, O Gorduysus, A Pekel, Y Baran, F Avcu, AU Ural Journal of endodontics 33 (12), 1450-1454, 2007 | 108 | 2007 |
| Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma F Firinci, M Karaman, Y Baran, A Bagriyanik, ZA Ayyildiz, M Kiray, ... International immunopharmacology 11 (8), 1120-1126, 2011 | 94 | 2011 |
| Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells Z Birsu Cincin, M Unlu, B Kiran, E Sinem Bireller, Y Baran, B Cakmakoglu Cellular Oncology 38, 195-204, 2015 | 79 | 2015 |
| Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest AA Gokbulut, E Apohan, Y Baran Hematology 18 (3), 144-150, 2013 | 79 | 2013 |
| Bioactive, functional and edible film-forming properties of isolated hazelnut (Corylus avellana L.) meal proteins LY Aydemir, AA Gökbulut, Y Baran, A Yemenicioğlu Food Hydrocolloids 36, 130-142, 2014 | 78 | 2014 |
| Molecular mechanisms of quercitrin-induced apoptosis in non-small cell lung cancer ZB Cincin, M Unlu, B Kiran, ES Bireller, Y Baran, B Cakmakoglu Archives of medical research 45 (6), 445-454, 2014 | 72 | 2014 |
| Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer M Kartal Yandım, E Apohan, Y Baran Cancer chemotherapy and pharmacology 71, 13-20, 2013 | 70 | 2013 |
| The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60 acute myeloid leukemia cells Z Cakir, G Saydam, F Sahin, Y Baran Journal of cancer research and clinical oncology 137, 279-286, 2011 | 70 | 2011 |
| Synthesis, cytotoxic and antimicrobial activities of novel cobalt and zinc complexes of benzimidazole derivatives E Apohan, U Yilmaz, O Yilmaz, A Serindag, H Küçükbay, O Yesilada, ... Journal of Organometallic Chemistry 828, 52-58, 2017 | 69 | 2017 |
| Novel agents targeting bioactive sphingolipids for the treatment of cancer A Adan-Gokbulut, M Kartal-Yandim, G İskender, Y Baran Current medicinal chemistry 20 (1), 108-122, 2013 | 69 | 2013 |
| Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF G Onalan, B Selam, Y Baran, M Cincik, R Onalan, U Gündüz, AU Ural, ... Human Reproduction 20 (9), 2391-2395, 2005 | 65 | 2005 |
| Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance A Camgoz, EB Gencer, AU Ural, Y Baran Leukemia & lymphoma 54 (6), 1279-1287, 2013 | 63 | 2013 |
